TGFβR-KO CAR-EGFR T-cells targeting TGFβR2 are also being investigated to enhance the anti-tumor activity of CAR T-cell therapy in EGFR-overexpressing solid tumors, though results have yet to be published (NCT04976218). This evidence concerns the gene EGFR and neoplasm.